240 results on '"Couvreur J"'
Search Results
52. Devenir des toxoplasmoses congénitales
- Author
-
Couvreur, J. and Thulliez, Ph.
- Published
- 1989
- Full Text
- View/download PDF
53. Chemo-Enzymatic Synthesis and Biological Assessment of p -Coumarate Fatty Esters: New Antifungal Agents for Potential Plant Protection.
- Author
-
Thaeder C, Stanek J, Couvreur J, Borrego C, Brunissen F, Allais F, Flourat AL, and Cordelier S
- Subjects
- Plants microbiology, Cell Membrane, Botrytis, Plant Diseases prevention & control, Plant Diseases microbiology, Antifungal Agents chemistry, Arabidopsis metabolism
- Abstract
One trend in agriculture is the replacement of classical pesticides with more ecofriendly solutions, such as elicitation, which is a promising approach consisting of stimulating the natural immune system of a plant to improve its resistance to pathogens. In this fashion, a library of p -coumaric-based compounds were synthesized in accordance with as many principles of green chemistry as possible. Then, these molecules were tested for (1) the direct inhibition of mycelium growth of two pathogens, Botrytis cinerea and Sclerotinia sclerotiorum , and (2) plasma membrane destabilization in Arabidopsis and rapeseed. Finally, the protective effect was evaluated on an Arabidopsis/ B. cinerea pathosystem. Total inhibition of the growth of both fungi could be achieved, and significant ion leakage was observed using dihydroxylated fatty p -coumarate esters. A direct effect on plants was also recorded as a ca. three-fold reduction in the necrosis area.
- Published
- 2023
- Full Text
- View/download PDF
54. Performance evaluation of the FAST™ System and the FAST-PBC Prep™ cartridges for speeded-up positive blood culture testing.
- Author
-
Verroken A, Hajji C, Bressant F, Couvreur J, Anantharajah A, and Rodriguez-Villalobos H
- Abstract
Objectives: As time to appropriate antimicrobial therapy is major to reduce sepsis mortality, there is great interest in the development of tools for direct identification (ID) and antimicrobial susceptibility testing (AST) of positive blood cultures (PBC). Very recently, the FAST™ System (Qvella) has been developed to isolate and concentrate microorganisms directly from PBCs, resulting in the recovery of a Liquid Colony™ (LC) within 30 min. The LC can be used as equivalent of an overnight subcultured colony for downstream testing. We aimed to evaluate the performances of the FAST™ System and FAST-PBC Prep™ cartridges by testing the resulting LC for direct ID, AST and rapid resistance detection., Materials and Methods: Prospectively, FAST™ System testing was carried out on each patient's first PBC with a monomicrobial Gram-stain result. In the second arm of the study, FAST™ System testing was carried out on blood cultures spiked with multidrug-resistant bacteria. Downstream testing using the LC included MALDI-TOF MS ID with the Bruker Biotyper
® smart system, rapid resistance detection testing including the Abbott Diagnostics Clearview™ PBP2a SA Culture Colony Test (PBP2a) and the Bio-Rad βLACTA™ Test (βLT). AST was performed using the Becton Dickinson Phoenix™ System or by Bio-Rad disk diffusion using filter paper disk following EUCAST 2020 breakpoint criteria., Results: FAST™ System testing was completed on 198 prospective PBCs and 80 spiked blood cultures. After exclusion of polymicrobial blood cultures, performance evaluation compared with standard of care results was carried out on 266 PBCs. Concordant, erroneous and no ID results included 238/266 (89.5%), 1/266 (0.4%), 27/266 (10.2%) PBCs, respectively. Sensitivity and specificity for PBP2a were 100% (10/10) and 75% (15/20), respectively. Sensitivity and specificity for βLT were 95.8% (23/24) and 100% (42/42), respectively. Categorical agreement for all 160 tested strains was 98% (2299/2346) with 1.2% (8/657) very major errors and 0.7% (10/1347) major errors., Conclusion: FAST™ System testing is a reliable approach for direct downstream testing of PBCs including MALDI-TOF MS ID, BD Phoenix™ and Bio-Rad disk diffusion AST as well as rapid resistance testing assays. Next steps include optimal integration of the FAST™ System in the PBC workflow with a view toward clinical studies., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Verroken, Hajji, Bressant, Couvreur, Anantharajah and Rodriguez-Villalobos.)- Published
- 2022
- Full Text
- View/download PDF
55. Intensification of p-coumaric acid heterologous production using extractive biphasic fermentation.
- Author
-
Combes J, Imatoukene N, Couvreur J, Godon B, Brunissen F, Fojcik C, Allais F, and Lopez M
- Subjects
- Coumaric Acids, Culture Media, Fermentation, Propionates, Saccharomyces cerevisiae
- Abstract
p-coumaric acid (p-CA) can be produced from D-glucose by an engineered S. cerevisiae strain. p-CA has antimicrobial properties and retro-inhibition activity. Moreover, p-CA is a hydrophobic compound, limiting its accumulation in fermentation broth. To overcome these issues all at once, a liquid-liquid extraction in-situ product recovery process using oleyl alcohol as extractant has been implemented in order to continuously extract p-CA from the broth. Media and pH impacts on strain metabolism were assessed, highlighting p-CA decarboxylase endogenous activity. Biphasic fermentations allowed an increase in p-CA respiratory production rates at both pH assessed (13.65 and 9.45 mg L
-1 .h-1 at pH 6 and 4.5, respectively) compared to control ones (10.5 and 7.5 mg L-1 .h-1 at pH 6 and 4.5, respectively). Biphasic fermentation effects on p-CA decarboxylation were studied showing that continuous removal of p-CA decreased its decarboxylation into 4-vinylphenol at pH 4.5 (57 mg L-1 in biphasic fermentation vs 173 mg L-1 in control one)., (Copyright © 2021 Elsevier Ltd. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
56. Hypothermia in trauma victims at first arrival of ambulance personnel: an observational study with assessment of risk factors.
- Author
-
Lapostolle F, Couvreur J, Koch FX, Savary D, Alhéritière A, Galinski M, Sebbah JL, Tazarourte K, and Adnet F
- Subjects
- Adult, Ambulances, Female, France epidemiology, Humans, Hypothermia etiology, Male, Middle Aged, Prospective Studies, Risk Factors, Wounds and Injuries complications, Emergency Medical Services, Hypothermia epidemiology, Wounds and Injuries epidemiology
- Abstract
Background: Hypothermia is common in trauma victims and is associated with increased mortality, however its causes are little known. The objective of this study was to identify the risk factors associated with hypothermia in prehospital management of trauma victims., Methods: This was an ancillary analysis of data recorded in the HypoTraum study, a prospective multicenter study conducted by the emergency medical services (EMS) of 8 hospitals in France. Inclusion criteria were: trauma victim, age over 18 years, and victim receiving prehospital care from an EMS team and transported to hospital by the EMS team in a medically equipped mobile intensive care unit. The following data were recorded: victim demographics, circumstances of the trauma, environmental factors, patient presentation, clinical data and time from accident to EMS arrival. Independent risk factors for hypothermia were analyzed in a multivariate logistic regression model., Results: A total of 461 trauma patients were included in the study. Road traffic accidents (N = 261; 57%) and falls (N = 65; 14%) were the main causes of trauma. Hypothermia (<35 °C) was present in 136/461 cases (29%). Independent factors significantly associated with the presence of hypothermia were: a low GCS (Odds Ratio (OR) = 0,87 ([0,81-0,92]; p < 0.0001), a low air temperature (OR = 0,93 [0,91-0,96]; p < 0.0001) and a wet patient (OR = 2,08 [1,08-4,00]; p = 0.03)., Conclusion: The incidence of hypothermia was high on EMS arrival at the scene. Body temperature measurement and immediate thermal protection should be routine, and special attention should be given to patients who are wet., Level of Evidence: Prospective, multicenter, open, observational study; Level IV.
- Published
- 2017
- Full Text
- View/download PDF
57. Risk factors for onset of hypothermia in trauma victims: the HypoTraum study.
- Author
-
Lapostolle F, Sebbah JL, Couvreur J, Koch FX, Savary D, Tazarourte K, Egman G, Mzabi L, Galinski M, and Adnet F
- Subjects
- Adult, Female, France epidemiology, Humans, Hypothermia epidemiology, Male, Middle Aged, Prospective Studies, Risk Factors, Hypothermia etiology, Wounds and Injuries complications
- Abstract
Introduction: Hypothermia is common in trauma victims and is associated with an increase in mortality. Its causes are not well understood. Our objective was to identify the factors influencing the onset of hypothermia during pre-hospital care of trauma victims., Methods: This was a multicenter, prospective, open, observational study in a pre-hospital setting., Results: A total of 448 patients were included. Hypothermia (<35 °C) on hospital arrival was present in 64/448 patients (14%). Significant factors associated with the absence of hypothermia in a multivariate analysis were no intubation: Odds Ratio: 4.23 (95% confidence interval 1.62 to 1.02); RTS: 1.68 (1.29 to 2.20); mobile unit temperature: 1.20 (1.04 to 1.38); infusion fluid temperature: 1.17 (1.05 to 1.30); patient not unclothed: 0.40 (0.18 to 0.90); and no head injury: 0.36 (0.16 to 0.83)., Conclusions: The key risk factor for the onset of hypothermia was the severity of injury but environmental conditions and the medical care provided by EMS were also significant factors. Changes in practice could help reduce the impact of factors such as infusion fluid temperature and mobile unit temperature.
- Published
- 2012
- Full Text
- View/download PDF
58. Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure.
- Author
-
Lapostolle F, Borron SW, Verdier C, Arnaud F, Couvreur J, Mégarbane B, Baud F, and Adnet F
- Subjects
- Aged, Aged, 80 and over, Antidotes administration & dosage, Cardiotonic Agents poisoning, Digoxin poisoning, Drug Overdose drug therapy, Female, France, Hospital Mortality, Humans, Immunoglobulin Fab Fragments administration & dosage, Immunologic Factors administration & dosage, Intensive Care Units statistics & numerical data, Male, Middle Aged, Multicenter Studies as Topic, Retrospective Studies, Antidotes therapeutic use, Cardiotonic Agents blood, Digoxin blood, Immunoglobulin Fab Fragments therapeutic use, Immunologic Factors therapeutic use
- Abstract
Objective: To evaluate the use of antidotal therapy in patients with an elevated digitalis concentration following chronic or acute exposure., Design and Setting: Retrospective review of patient records over 2 years in 20 city hospitals in France., Patients: Overall 838 patients with an elevated serum digitalis concentration (digoxin > 1.95ng /ml or digitoxin > 23ng /ml) were included in the study. Of these, 67 (8%) had received antidotal therapy with Fab fragments., Measurements and Results: The relationships between previously reported prognostic criteria and use of antidotal therapy were investigated. We identified five independent factors that were associated with the use of antidotal therapy: acute overdose (OR 15.74), Fab fragment availability in the hospital (11.06), serum potassium (1.81), and heart rate (0.96). Mortality was significantly lower in Fab-treated (6%, 4/67) than untreated patients (15%, 117/770)., Conclusions: Antidotal therapy is underused in patients with an elevated digitalis concentration especially in patients with chronic digitalis exposure. These patients in our series presented a higher mortality rate than patients with acute poisoning. Although they were older and tended to have a history of cardiac disease, they did not differ from patients with acute poisoning with regard to the main severity criteria and prognostic factors. The use of identical criteria for antidotal treatment after acute and chronic poisoning should help optimize outcomes. Fab fragment availability is insufficient in France but ranks only second after type of poisoning (acute or chronic) in the multivariate association with Fab treatment.
- Published
- 2008
- Full Text
- View/download PDF
59. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.
- Author
-
Brézin AP, Thulliez P, Couvreur J, Nobré R, Mcleod R, and Mets MB
- Subjects
- Child, Child, Preschool, Drug Therapy, Combination, Female, Gestational Age, Humans, Infant, Male, Pregnancy, Pregnancy Complications, Parasitic epidemiology, Prenatal Care, Pyrimethamine therapeutic use, Spiramycin therapeutic use, Toxoplasmosis, Congenital epidemiology, Treatment Outcome, Visual Acuity, Antiprotozoal Agents therapeutic use, Chorioretinitis diagnosis, Infectious Disease Transmission, Vertical prevention & control, Pregnancy Complications, Parasitic drug therapy, Toxoplasmosis, Congenital drug therapy, Toxoplasmosis, Ocular diagnosis
- Abstract
Purpose: To describe the ophthalmologic outcomes of cases of congenital toxoplasmosis treated prenatally and postnatally., Design: Observational case series., Method: Follow-up ophthalmologic examinations of 18 children born to mothers who were infected before 25 weeks gestation were performed concurrently by two ophthalmologists. The infection in these children was first suspected when their mothers seroconverted during gestation. Toxoplasmic infection of the fetus was diagnosed by fetal blood or amniotic fluid analysis. Mothers were treated by a regimen of alternating pyrimethamine-sulfonamides and spiramycin during gestation. Pyrimethamine-sulfonamides treatment was continued from birth to 1 year of age., Results: The median age of the children was 4.5 years (range 1-11), when the follow-up ophthalmologic examinations were performed. Visual acuity was decreased in only one child, who had extensive bilateral macular and peripheral lesions. A posterior pole scar was noted in four eyes (four children) for whom visual acuity remained normal. Peripheral lesions were observed in nine eyes (five children). Both eyes were normal in 11 of 18 (61%) of the children., Conclusions: In these children at a high risk for congenital toxoplasmic retinochoroiditis, a favorable visual outcome was observed in all but one case.
- Published
- 2003
- Full Text
- View/download PDF
60. Cotrimoxazole for prenatal treatment of congenital toxoplasmosis?
- Author
-
Derouin F, Jacqz-Aigrain E, Thulliez P, Couvreur J, and Leport C
- Subjects
- Animals, Disease Models, Animal, Female, Humans, Mice, Pregnancy, Toxoplasmosis drug therapy, Toxoplasmosis, Animal drug therapy, Toxoplasmosis, Congenital prevention & control, Anti-Infective Agents therapeutic use, Pregnancy Complications, Parasitic drug therapy, Toxoplasmosis, Congenital drug therapy, Trimethoprim, Sulfamethoxazole Drug Combination therapeutic use
- Abstract
Congenital toxoplasmosis is still one of the most frequent causes of fetal death. Despite a significant improvement in diagnosis, particularly in utero diagnosis, maternal treatment is only partially effective in preventing transmission to the fetus and treating fetal infection. Maternal treatment is based on drugs developed 50 years ago, which may have limited efficacy (spiramycin) or serious side-effects (pyrimethamine). Data on the use of cotrimoxazole in mouse models of toxoplasmosis and for preventing toxoplasmic encephalitis in patients suffering from AIDS have led Francis Derouin and colleagues to consider the potential of cotrimoxazole for prenatal prevention and treatment of toxoplasmic fetal death.
- Published
- 2000
- Full Text
- View/download PDF
61. Serologic rebounds after one-year-long treatment for congenital toxoplasmosis.
- Author
-
Djurkovic-Djakovic O, Romand S, Nobrè R, Couvreur J, and Thulliez P
- Subjects
- Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Immunoglobulin A blood, Immunoglobulin M blood, Infant, Newborn, Male, Pregnancy, Prognosis, Retrospective Studies, Serologic Tests, Antibodies, Protozoan blood, Antiprotozoal Agents administration & dosage, Pyrimethamine administration & dosage, Sulfadiazine administration & dosage, Toxoplasmosis, Congenital diagnosis, Toxoplasmosis, Congenital drug therapy
- Published
- 2000
- Full Text
- View/download PDF
62. [Problems of congenital toxoplasmosis. Evolution over four decades].
- Author
-
Couvreur J
- Subjects
- Female, History, 20th Century, Humans, Infant, Newborn, Male, Pregnancy, Toxoplasmosis, Congenital history, Toxoplasmosis, Congenital therapy, Toxoplasmosis, Congenital diagnosis
- Abstract
EFFECT OF PREVENTIVE MEASURES: The development of reliable routine serology tests and the demonstration of the high prevalence of toxoplasmosis in France led to mandatory prospective screening of pregnant women in 1978, followed by prenatal screening in 1985. In addition, in utero diagnosis, first on fetal blood and now with the reliable and safe method using polymerase chain reaction on amniotic fluid, formally identifies the parasite. THE SITUATION TODAY: A comparison of the experience of a specialized center in Paris during three different periods over the last 40 years showed that currently 71% of all cases of congenital toxoplasmosis are infraclinical at birth and only 5% are severe. Mean incidence of seroconversion during pregnancy is 1.48%, with a 40% risk of fetal contamination if no treatment is given. The risk of overt fetopathy predominantly concerns maternal infections occurring prior to 26 weeks gestation. IN UTERO TREATMENT: Positive PCR diagnosis on amniotic fluid imposes serial ultrasound examinations to identify any fetopathy and an in utero treatment by giving the mother the pyrimethamine-sulfadiazine combination. Biological results are favorable. POST-NATAL TREATMENT: Post-natal treatment is indicated even in latent forms and should be continued for the first year of life. The pyrimethamine-sulfadiazine combination is the only pharmaceutical regimen with well-proven efficacy. New compounds should allow better prophylaxis against maternofetal contamination or improved post-natal treatment. RECURRENCE: In 70% of the cases, serology tests become positive again, but are not associated with significantly increased risk of ocular recurrence.
- Published
- 1999
63. Survey of out-of-hospital emergency intubations in the French prehospital medical system: a multicenter study.
- Author
-
Adnet F, Jouriles NJ, Le Toumelin P, Hennequin B, Taillandier C, Rayeh F, Couvreur J, Nougière B, Nadiras P, Ladka A, and Fleury M
- Subjects
- Clinical Protocols, Emergency Medical Services, France, Humans, Hypnotics and Sedatives, Prospective Studies, Statistics, Nonparametric, Surveys and Questionnaires, Emergency Treatment adverse effects, Intubation, Intratracheal adverse effects
- Abstract
Study Objective: To determine the clinical characteristics of endotracheal intubation in the French emergency prehospital medical system and compare these data with those of other systems., Methods: This study was performed in lle de France (Paris Region) in mobile ICUs staffed by physicians. This prospective, descriptive study involved completion of a questionnaire by the operator just after endotracheal intubation was performed., Results: Six hundred eighty-five (99.1%) of 691 consecutive prehospital intubations were performed successfully in the field. The orotracheal route was used in 96.0%, and no surgical approaches such as cricothyroidotomy were used. Mechanical complications occurred in 84 patients, at a rate of 15.9% for nonarrest patients and 8.1% for arrest patients. A wide variety of sedation protocols were used. Difficult intubations (10.8%) were comparable in incidence to the number seen in US emergency departments, not US prehospital systems. By the same token, intubation success rates (99.1%) were comparable to US EDs and much higher than US prehospital results., Conclusion: The characteristics of French prehospital airway management differ significantly from those of other countries. These differences may be explained by differences in approach to prehospital management rather than differences of skill.
- Published
- 1998
- Full Text
- View/download PDF
64. Idiopathic pulmonary fibrosis in infants.
- Author
-
Osika E, Muller MH, Boccon-Gibod L, Fauroux B, Sardet A, Grosskopf C, Couvreur J, Tournier G, and Clement A
- Subjects
- Biopsy, Bronchoalveolar Lavage, Bronchoscopy, Fatal Outcome, Female, Glucocorticoids therapeutic use, Humans, Infant, Male, Oxygen Inhalation Therapy, Pulmonary Fibrosis diagnosis, Pulmonary Fibrosis therapy
- Abstract
Idiopathic pulmonary fibrosis is a poorly characterized disease in infants. In the present report, we reviewed our experience with 10 infants during a 10-year period. In 9 patients, onset of symptoms occurred before the age of 2 months and included tachypnea, cough, and inadequate weight gain. However, despite the presence of these symptoms, diagnosis was delayed for 3 months at which time the infants were referred to the pediatric pulmonary department, when the diagnosis was confirmed by open lung biopsy. At the time of admission, bronchoscopy with alveolar lavage was performed in 9 children and showed severe alveolitis with an increase in the neutrophil count. Nine infants were treated with prednisone alone or in combination with chloroquine, colchicine, or cyclophosphamide; all these patients died despite treatment. One infant was treated with pulses of methylprednisolone because of a failure in response to oral prednisone. This girl who displayed similar clinical, radiological, and histological abnormalities as the other children at the time of diagnosis is the only child still alive after 3 years of follow-up. She is now free of respiratory symptoms and has a normal growth curve. The present report raised two important points: (1) a thorough evaluation of characteristic symptoms should lead to an early diagnosis of pulmonary fibrosis in infants; and (2) administration of pulse therapy using corticosteroids has been helpful and needs to be evaluated further.
- Published
- 1997
- Full Text
- View/download PDF
65. [Acquired toxoplasmosis of ocular or neurologic site: 49 cases].
- Author
-
Couvreur J and Thulliez P
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Female, France epidemiology, Humans, Infant, Male, Meningoencephalitis parasitology, Middle Aged, Recurrence, Toxoplasmosis, Cerebral complications, Toxoplasmosis, Cerebral immunology, Toxoplasmosis, Ocular complications, Toxoplasmosis, Ocular immunology, Toxoplasmosis, Cerebral epidemiology, Toxoplasmosis, Ocular epidemiology
- Abstract
Objectives: Over a period of 13 years (1982-1995), 49 cases of acquired toxoplasmosis complicated with ocular and/or neurologic or meningeal involvement were observed in our toxoplasmosis laboratory. This series includes 43 cases of isolated ocular lesions, 3 cases of meningoencephalitis (associated with retinochoroiditis in 1 case), 1 case of meningitis with uveitis, 1 case of polyradiculoneuritis and 1 case of facial nerve palsy., Methods: The patients were aged 1 to 62 years. None had either spontaneous or iatrogenic immunodeficiency. There were two steps in the diagnosis. First congenital infection was eliminated on one or several of the following criteria: any possibility of maternal infection during pregnancy ruled out in 26 cases, evidence of recent acquired infection (i.e. clinical and/or serological evidence of recent acquired toxoplasmosis in 17 cases, retinochoroiditis in non-twin siblings in 3 cases). The second step was to confirm the diagnosis of toxoplasma infection. Apart from serological evidence of recent infection, confirmation included specific local antibody synthesis in the aqueous humor of the eye and/or in cerebro-spinal fluid or ocular lesions characteristic of toxoplasmosis and absence of other etiology., Results: Ocular lesions were unilateral in 43 cases among 45. A mean follow-up of 37.9 months revealed relapses in 14 among 36 patients (39%). As routine serological examination for toxoplasmosis is compulsory in France since 1978, it was possible to document retrospectively the immune status of the mothers of many of the patients of the present series during pregnancy and to rule out congenital toxoplasmosis in a number of cases. This might explain the discrepancy between the relatively large number of cases in the present series and the fact that complicated acquired toxoplasmosis has been considered hitherto as relatively rare in immunocompetent patients., Conclusion: Based on the epidemiology of ocular toxoplasmosis and the data obtained here, it is suggested that the acquired pattern of ocular toxoplasmosis might be more frequent than estimated up to now.
- Published
- 1996
66. [Acquired cerebral toxoplasmosis in an non-immunosuppressed child].
- Author
-
Desguerre I, Pedespan JM, Buissonnière R, Couvreur J, and Ponsot G
- Subjects
- Child, Preschool, Drug Therapy, Combination, Female, Humans, Immunocompetence, Magnetic Resonance Imaging, Pyrimethamine administration & dosage, Pyrimethamine therapeutic use, Sulfadiazine administration & dosage, Sulfadiazine therapeutic use, Toxoplasmosis, Cerebral diagnosis, Toxoplasmosis, Cerebral drug therapy, Toxoplasmosis, Cerebral immunology
- Abstract
Background: Postnatally acquired toxoplasmosis is relatively common as an unapparent infection. When there are severe clinical manifestations such as encephalitis, pneumonia and myocarditis, the patient should be checked for immunocompetence deficiencies., Case Report: A two-year old girl living in French Guyana suffered from acute respiratory distress due to interstitial pneumonia plus pericarditis that was treated by closed pericardial aspiration. Palsies of four limbs and chorioretinitis gradually appeared. The CSF protein content was elevated, 1 g/l, but the number of cells was normal. Serologic tests indicated a recent toxoplasma infection; she was given sulfadoxine, pyrimethamine and spiramycin. Her neurologic condition and the persistent antibodies, indicating active disease, led to her transfer to our Department 3 months after the onset of the disease. The CSF contained 47 cells/mm3 and 0.8 g/l proteins. Measurement of both IgM and IgG classes of toxoplasma antibodies showed persistent high titers in the blood and CSF. The CT scan showed numerous calcifications in the brain and hypodense areas in the frontal and parietal lobes. The MRI showed extensive changes. The severity of the disease in this girl led us to study her immune system. It was normal. The girl was given 6-week treatments with pyrimethamine-sulfadiazine for 2 years. This treatment stabilized the disease, but her titers of toxoplasma antibodies remained high., Conclusion: The initial clinical presentation of the disease in this patient and persistent high titers of toxoplasma antibodies, especially of the IgM class, argue against the possibility of congenital toxoplasmosis and favor the diagnosis of acquired disease in a patient who has no immune deficiency.
- Published
- 1993
67. [Respiratory virus infections in children].
- Author
-
Sardet A and Couvreur J
- Subjects
- Age Factors, Child, Female, France epidemiology, Humans, Incidence, Male, Respiratory Syncytial Viruses isolation & purification, Respiratory Tract Infections epidemiology, Respirovirus Infections epidemiology, Respirovirus Infections microbiology, Virus Diseases epidemiology, Respiratory Tract Infections microbiology, Virus Diseases microbiology
- Abstract
Eighty to ninety percent of pathogens responsible for acute respiratory infections in children are viruses, but despite advances in virology these organisms are isolated in only 20 to 45 percent of the cases. Studies conducted outside hospitals have provided epidemiological data. The virus most frequently encountered is the respiratory syncytial virus. The main clinical feature of these respiratory viral infections is obstruction of the bronchioles, and their immediate or delayed danger is the risk of chronic obstructive bronchitis. Treatment is symptomatic, but specific antiviral agents, notably ribavirin, are useful in severe infections.
- Published
- 1993
68. [Heart or heart-lung transplantation and toxoplasmosis].
- Author
-
Couvreur J, Tournier G, Sardet-Frismand A, and Fauroux B
- Subjects
- Cyclosporine therapeutic use, Cytomegalovirus Infections etiology, Drug Therapy, Combination, Humans, Immunity, Cellular, Pyrimethamine therapeutic use, Risk Factors, Serologic Tests, Sulfadiazine therapeutic use, Toxoplasmosis diagnosis, Toxoplasmosis drug therapy, Toxoplasmosis immunology, Heart Transplantation adverse effects, Heart-Lung Transplantation adverse effects, Toxoplasmosis etiology
- Abstract
Among all organ transplantations, those of heart or heart-lung carry the greatest risk of toxoplasmosis. The disease is observed mainly when the donor is seropositive and the recipient seronegative. In these mismatched couples the risk may be as high as 57 percent. Cardiac tissue transplants are responsible for most contaminations. A subclinical serological reactivation can be observed in seropositive recipients. Patent forms are associated with seroconversion in seronegative subjects. Toxoplasmosis is often severe with multivisceral foci; interstitial pneumonia is possible. The serological diagnosis is easy in cases with significant antibody movements, but it may be difficult if the titre is low or stable. The parasitological diagnosis rests on the isolation of toxoplasma in blood, cerebrospinal fluid, bronchoalveolar lavage fluid and cardiac or cerebral biopsy. Immune defence against toxoplasmosis is primarily cellular, with lymphocytosis and inversion of the CD4/CD8 ratio. Macrophages play a crucial role. Interferon-gamma is the major mediator of cellular resistance. In spite of its immunosuppressive action, cyclosporin clearly has an antiparasitic action in vitro and in vivo. A cytomegalovirus infection might facilitate toxoplasma reactivation. Prevention of toxoplasmosis in transplant recipients includes systematic serology of the recipient and, if possible, the donor, detection of mismatched couples and systematic treatment with pyrimethamine of recipients at risk (in seronegative recipients, this drug has reduced the risk from 57 to 14 percent). Cyclosporin should be used as immunosuppressant in preference to other drugs of this kind. Corticosteroids administered in rejections increase the risk of toxoplasmosis.
- Published
- 1992
69. [Congenital deglutition disorder revealing cerebral stem disorders. 12 cases with neurophysiological study].
- Author
-
Renault F and Couvreur J
- Subjects
- Brain Diseases physiopathology, Deglutition Disorders physiopathology, Electromyography, Female, Humans, Infant, Infant, Newborn, Male, Brain Diseases complications, Brain Stem physiopathology, Deglutition Disorders etiology
- Abstract
Background: Respiratory problems in neonates and infants may be the result of a variety of neuromuscular dysfunctions. Neurologic evaluation of functions, such as sucking and swallowing, may be difficult in these very young infants and can be helped by neurophysiological studies., Methods: 12 infants admitted because of repeated episodes of respiratory obstruction due to difficulties of sucking and/or swallowing took part in the study. The neurophysiological studies included electromyography of the facial, lingual and pharyngeal muscles, brain stem auditory evoked potentials and measurement of the blink reflexes. The results were correlated with events during the perinatal period and those that occurred during the follow-up., Results: Dysphagia was evident from the neonatal period; it was complicated by nasal reflux and aspiration bronchopneumopathy. Facial diplegia was observed in 8 patients. 9 patients failed to thrive. The electromyographic patterns showed partial denervation of the facial, lingual and pharyngeal muscles in all cases; the blink reflex was altered in 11 cases, and the brain stem evoked potentials were abnormal in 3 of the 8 cases tested. 7 of the infants had histories of pregnancy and obstetrical abnormalities, and/or fetal distress. The swallowing function partially improved within several months., Conclusions: Neurophysiological studies indicate neurofunctional alterations in the VII, IX, X and XII cranial nerve nuclei, V and VII pathways and the auditory tract. These lesions and the time course of improvement suggest that they are due to pre- or perinatal anoxo-ischemic brain stem injury.
- Published
- 1992
70. [Recurrent bronchopneumopathies in the infant due to swallowing dyspraxia. Two cases].
- Author
-
Renault F, Couvreur J, Ostre C, and Tournier G
- Subjects
- Deglutition Disorders diagnosis, Diagnosis, Differential, Female, Humans, Infant, Neurophysiology, Recurrence, Deglutition Disorders complications, Respiratory Tract Infections etiology
- Abstract
In two infants with recurrent lower respiratory tract infections starting within a few weeks of birth, dynamic electromyographic studies of sucking and swallowing evidenced a disorder of lingual and pharyngeal activities responsible for the episodes of aspiration. The central location of the anomaly was demonstrated by the absence of peripheral neuromuscular anomalies and by the presence of impaired blinking reflexes and brain stem potential anomalies. These neurofunctional anomalies improved over time and magnetic resonance imaging failed to disclose and structural anomalies of the central nervous system. The occurrence of the swallowing disorder as an isolated manifestation and its long duration, with follow-ups of 23 months and 4 years, are two unique features in these cases. Neurophysiologic investigations are essential for documenting the neurologic etiology of the swallowing disorders, demonstrating their location above or within the medulla oblongata, and differentiating functional and organic anomalies.
- Published
- 1992
71. [Congenital toxoplasmosis. Epidemiology, physiopathology, evolution, diagnosis, prognosis, principles of the treatment, prevention].
- Author
-
Couvreur J
- Subjects
- Female, Humans, Pregnancy, Prognosis, Toxoplasmosis, Congenital diagnosis, Toxoplasmosis, Congenital epidemiology, Toxoplasmosis, Congenital physiopathology, Toxoplasmosis, Congenital therapy
- Published
- 1992
72. [Treatment understanding and compliance in asthma of children. Results of a prospective survey].
- Author
-
Fauroux B, Just J, Couvreur J, Grimfeld A, and Tournier G
- Subjects
- Adolescent, Adrenal Cortex Hormones therapeutic use, Adrenergic beta-Agonists therapeutic use, Adult, Child, Child, Preschool, Cromolyn Sodium therapeutic use, Drug Therapy, Combination, Histamine Antagonists therapeutic use, Humans, Parent-Child Relations, Prospective Studies, Surveys and Questionnaires, Theophylline therapeutic use, Asthma drug therapy, Health Surveys, Parents education, Patient Compliance
- Abstract
Compliance with treatment is a crucial factor in the management of asthmatic children which depends on the understanding of the disease and its treatment. The understanding of, and compliance with treatment were evaluated by means of a questionnaire in 50 parents of asthmatic children. 50% of these parents used anti-histamines as maintenance treatment and 30% also used these drugs during attacks. Half the parents knew about the bronchodilator effects of theophylline and B2-agonists. 42% and 30% respectively of the parents thought that the side-effects of theophylline or corticosteroids were few or inexistent; 86% claimed regular attendance to out-patient clinics, but 30% confessed that they had forgotten such drugs as theophylline and antihistamines. 50% took the appropriate therapeutic measures when confronted with a moderate or severe attack of asthma. Each child received 2.3 drugs on average for his or her asthma. This study shows that parents have an insufficient knowledge of asthma treatments, and this may partially explain the poor compliance with therapy as well as the morbidity and mortality associated with childhood asthma.
- Published
- 1992
73. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
- Author
-
Couvreur J
- Subjects
- Drug Therapy, Combination, Female, Humans, Pregnancy, Spiramycin therapeutic use, Pyrimethamine therapeutic use, Sulfadiazine therapeutic use, Toxoplasmosis, Congenital drug therapy
- Published
- 1991
74. [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides].
- Author
-
Couvreur J, Thulliez P, Daffos F, Aufrant C, Bompard Y, Gesquière A, and Desmonts G
- Subjects
- Drug Therapy, Combination, Female, Humans, Infant, Infant, Newborn, Pregnancy, Prenatal Care methods, Pyrimethamine administration & dosage, Spiramycin therapeutic use, Sulfadiazine administration & dosage, Fetal Diseases drug therapy, Pyrimethamine therapeutic use, Sulfadiazine therapeutic use, Toxoplasmosis, Congenital drug therapy
- Abstract
The mothers of 52 cases of toxoplasmic fetopathy diagnosed in utero by fetal blood and/or amniotic fluid sampling were treated with the combination pyrimethamine-sulfadiazine (or sulfisoxazole) and by spiramycine. The infants were compared with 51 other infants with congenital toxoplasmosis whose mothers had received spiramycine alone. Patients of both groups received the same pyrimethamine-sulfadiazine and spiramycine treatment after birth. Parasitologic examination of the placenta was positive in 42 and 76.6% of patients, in group I and group II respectively. The newborns had specific IgM in 17.4 and 69.2% of cases respectively in both groups. These differences were significant. The mean specific IgG titer was significantly reduced at birth and 4 to 6 months of age in the first group. Patients in group I had more often subclinical infection than patients of the comparison group: 57% vs 33.3%. They had less often a high cerebro-spinal protein content during the first week. Prenatal treatment with pyrimethamine-sulfadrugs resulted in a less progressing infection at birth. However in cases with clinically patent toxoplasmosis, the frequency of overt localizations and their sequellae was not significantly altered. This might be related to a relatively late onset of the treatment. The pyrimethamine-sulfadrug combination given to mothers of proved infected fetuses can be rewarding. The indication might be extended to well-documented seroconverted mothers if, in the future, the acquired experience and necessary pharmacological studies bring the proof of its innocuousness.
- Published
- 1991
75. [6 cases of toxoplasmosis in twins].
- Author
-
Couvreur J, Thulliez T, Daffos F, Aufrant C, Bompard Y, Goumy P, and Tournier G
- Subjects
- Adult, Female, Fetal Diseases diagnosis, Humans, Infant, Newborn, Male, Maternal-Fetal Exchange, Pregnancy, Prenatal Diagnosis, Prospective Studies, Spiramycin therapeutic use, Toxoplasmosis diagnosis, Toxoplasmosis drug therapy, Diseases in Twins, Toxoplasmosis, Congenital, Twins
- Abstract
Studies of congenital toxoplasmosis in twins confirm the definite role of the placenta in the modalities and mechanism of fetal contamination. In single-chorion twin pregnancies, clinical manifestations are generally identical in both infants. Conversely, twins from double-chorion pregnancies usually have different clinical patterns; occasionally, only one of the twins is affected (1 case). The diagnosis can be ascertained antenatally by sampling blood from each of the fetuses (2 cases). The cases reported herein illustrate some of the diagnostic pitfalls that may lead to inappropriate discontinuation of monitoring and treatment: negative placental studies, absence of specific IgM antibodies, transient fall in IgG antibody titers, delayed fetal contamination after a negative fetal blood study, and need for routine tests for increased CSF albumin levels.
- Published
- 1991
76. [The Wurzburg titanium miniplate system: evaluation of 3-year utilization].
- Author
-
Couvreur J and Wackens G
- Subjects
- Humans, Jaw Fractures surgery, Skull Fractures surgery, Bone Plates, Facial Bones surgery, Titanium
- Abstract
In this article the use of Titanium miniplates in the maxillo-facial surgery is being examined. After a literature-study concerning the qualities of Titanium and the advantages, disadvantages aswell as indications of the miniplates, the stability of osteotomies using this system is being traced, aswell as its eventual developments. From this research it becomes clear that the miniplates indeed contribute to greater stability of the skeletal fixation in maxillo-facial surgery.
- Published
- 1990
77. [Cystic fibrosis in infants revealed by severe respiratory distress. Mid-term course].
- Author
-
Sardet A, Couvreur J, Costil J, Just J, Boule M, and Tournier G
- Subjects
- Child, Preschool, Cystic Fibrosis diagnosis, Cystic Fibrosis epidemiology, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Retrospective Studies, Cystic Fibrosis complications, Respiratory Distress Syndrome, Newborn etiology
- Abstract
We report the follow-up of 13 infants aged 2.5 to 24 months in whom cystic fibrosis disease presented as respiratory distress. All infants received an intensive treatment. Mean clinical, radiological and microbiological follow-up was 3.1 years. Ten children aged 1.5 to 8.5 years are still alive. One of them presents with serious respiratory failure, with a Shwachman score of 50. The Shwachman score is between 85 and 70 for 8 of 13 and 65 for one. The prognosis of this group did not differ from the one usually observed in the disease. It depends partially on early intensive care management and is not altered by mechanical ventilation.
- Published
- 1990
78. [Congenital toxoplasmosis. 5 cases of mother-to-child transmission of pre-pregnancy infection].
- Author
-
Desmonts G, Couvreur J, and Thulliez P
- Subjects
- Female, Fetal Diseases diagnosis, Humans, Immunity, Cellular, Infant, Infant, Newborn, Male, Pregnancy, Prenatal Diagnosis, Serologic Tests, Toxoplasmosis, Congenital complications, Toxoplasmosis, Congenital diagnosis, Fetal Diseases etiology, Toxoplasmosis, Congenital transmission
- Abstract
Five cases of congenital toxoplasmosis consecutive to a maternal toxoplasma infection that had preceded pregnancy were observed. One woman with normal immune system had developed a well-documented lymph node toxoplasmosis 2 months before conceiving. Four women had chronic toxoplasmosis diagnosed in the course of an immunosuppressive disease: Hodgkin's disease in 1 case, systemic lupus erythematosus in 2 cases and pancytopenia in 1 case. Toxoplasmosis had been recognized 3, 5 and 10 years respectively before conception in 3 women, and at an uncertain date in 1 woman. Three women had received corticosteroids during pregnancy, and 2 had undergone splenectomy. Among the 6 children (2 were twins), 1 presented with severe foetal disease at birth, 1 developed lethal systemic toxoplasmosis after birth, 1 showed hydrocephalus with therapeutically well-controlled chorioretinitis, 1 had isolated eye lesion and 2 had asymptomatic infection. The parasite seems to have been transmitted after the 20th week of pregnancy in all cases. The physiopathology of mother-to child toxoplasma transmission, the role played by maternal immunodeficiency and the practical implications of these exceptional cases are discussed.
- Published
- 1990
79. Assignment of cathepsin E (CTSE) to human chromosome region 1q31 by in situ hybridization and analysis of somatic cell hybrids.
- Author
-
Couvreur JM, Azuma T, Miller DA, Rocchi M, Mohandas TK, Boudi FA, and Taggart RT
- Subjects
- Blotting, Southern, Cathepsin E, DNA Probes, Humans, Hybrid Cells, Nucleic Acid Hybridization, Cathepsins genetics, Chromosome Mapping, Chromosomes, Human, Pair 1
- Abstract
A full length cathepsin E (CTSE) cDNA clone was used to assign the corresponding gene to human chromosome region 1q31 by in situ hybridization. Southern blot analysis of DNA from three independent human x rodent somatic cell hybrids containing X;1 translocations confirmed the assignment of the CTSE gene to the distal region of the long arm of chromosome 1.
- Published
- 1990
- Full Text
- View/download PDF
80. [Congenital bronchopulmonary malformations].
- Author
-
Couvreur J
- Subjects
- Abnormalities, Multiple diagnosis, Bronchopulmonary Sequestration diagnosis, Humans, Lung blood supply, Mediastinal Cyst diagnosis, Trachea abnormalities, Bronchi abnormalities, Lung abnormalities
- Published
- 1984
81. Congenital toxoplasmosis. A prospective study of 378 pregnancies.
- Author
-
Desmonts G and Couvreur J
- Subjects
- Antibodies analysis, Female, Humans, Infant, Newborn, Leucomycins therapeutic use, Methods, Paris, Placenta, Pregnancy, Prospective Studies, Pyrimethamine therapeutic use, Serologic Tests, Sulfonamides therapeutic use, Toxoplasma immunology, Toxoplasma isolation & purification, Toxoplasmosis diagnosis, Toxoplasmosis drug therapy, Toxoplasmosis epidemiology, Toxoplasmosis immunology, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious epidemiology, Toxoplasmosis, Congenital diagnosis, Toxoplasmosis, Congenital epidemiology, Toxoplasmosis, Congenital immunology
- Published
- 1974
- Full Text
- View/download PDF
82. [Liebow's desquamative interstitial pneumonia. Apropos of a case in an infant].
- Author
-
Roussey M, Jouan H, Marechal C, Couvreur J, Boccon-Gibod L, Kerisit J, and Senecal J
- Subjects
- Humans, Infant, Newborn, Infant, Newborn, Diseases diagnosis, Pulmonary Fibrosis diagnosis, Infant, Newborn, Diseases pathology, Pulmonary Fibrosis pathology
- Abstract
Case report of a Liebow's desquamative interstitial pneumonia in a 3 week-old infant. The disease resulted in permanent respiratory failure. Steroid therapy had no durable effect and death occurred at 4 1/2 months of age.
- Published
- 1983
83. [Pneumological aspects of bronchial foreign bodies in children. Experience with 100 cases].
- Author
-
Khiati M, Couvreur J, Grimfeld A, Le Moing G, and Tournier G
- Subjects
- Child, Preschool, Follow-Up Studies, Humans, Lung Diseases etiology, Bronchi, Foreign Bodies
- Abstract
100 cases of bronchial foreign body seen over a period of 4 years represent 1.2% of the admissions of a paediatric pneumology unit; 73% of the children were aged between 6 months and 3 years. The foreign body was vegetable in 61% of cases (a peanut in 44% of cases). The time between the inhalation and the endoscopic diagnosis was greater than 7 days in 70% of cases and greater than 30 days in 37% of cases. Removal of the foreign body was possible in all but one case. In particular, the authors studied the pneumological implications of a foreign body: the value of a quantitative bacteriological study of the bronchial secretions, which was significant in 43% of cases, and detection of the sequelae by prospective clinical and functional surveillance with a follow-up of 3 to 24 months. After 6 months, persistent radiological abnormalities were found in 40% of cases, perfusion disorders were found in 35% and ventilation disorders were found in 64%. A surgical operation was performed in 7 cases: one case of bronchotomy for extraction of the foreign body and 6 cases of parenchymal excision, including 2 total pneumonectomy for a destroyed lung. These were no death. The pathophysiology of the complications of functional disorders and of dilatation of the bronchi is discussed in the context of the experience gained from this series.
- Published
- 1984
84. [A homogeneous series of 210 cases of congenital toxoplasmosis in 0 to 11-month-old infants detected prospectively].
- Author
-
Couvreur J, Desmonts G, Tournier G, and Szusterkac M
- Subjects
- Congenital Abnormalities diagnosis, Eye Diseases diagnosis, Female, Gestational Age, Humans, Infant, Infant, Newborn, Male, Pregnancy, Prospective Studies, Toxoplasmosis, Congenital cerebrospinal fluid, Toxoplasmosis, Congenital transmission, Toxoplasmosis, Congenital diagnosis
- Published
- 1984
85. [Congenital tuberculosis].
- Author
-
Couvreur J
- Subjects
- Female, Humans, Infant, Newborn, Male, Maternal-Fetal Exchange, Obstetric Labor, Premature etiology, Pregnancy, Tuberculosis, Pulmonary diagnosis, Tuberculosis, Pulmonary congenital
- Published
- 1984
86. [Treatment of toxoplasmosis acquired during pregnancy with spiramycin].
- Author
-
Couvreur J and Desmonts C
- Subjects
- Female, Fetal Death epidemiology, Humans, Infant, Newborn, Placenta parasitology, Pregnancy, Toxoplasma isolation & purification, Toxoplasmosis, Congenital epidemiology, Leucomycins therapeutic use, Pregnancy Complications, Infectious drug therapy, Toxoplasmosis drug therapy
- Published
- 1983
87. Lymphocyte transformation in the diagnosis of congenital toxoplasma infection.
- Author
-
Wilson CB, Desmonts G, Couvreur J, and Remington JS
- Subjects
- Antibodies analysis, Antigens, Child, Child, Preschool, Female, Fluorescent Antibody Technique, Humans, Immunoglobulin M analysis, Infant, Infant, Newborn, Pregnancy, Prospective Studies, Toxoplasma immunology, Toxoplasma isolation & purification, Lymphocyte Activation, Toxoplasmosis, Congenital diagnosis
- Published
- 1980
- Full Text
- View/download PDF
88. [Interstitial pneumonia due to Chlamydia trachomatis in infants. Three cases (author's transl)].
- Author
-
Couvreur J, Tournier G, Grimfeld A, and Le Moing G
- Subjects
- Chlamydia trachomatis isolation & purification, Female, Humans, Immunoglobulins analysis, Infant, Infant, Newborn, Lung diagnostic imaging, Male, Pulmonary Fibrosis diagnosis, Pulmonary Fibrosis drug therapy, Radiography, Serologic Tests, Chlamydia Infections diagnosis, Chlamydia Infections drug therapy, Pulmonary Fibrosis microbiology
- Abstract
The early onset of the disease (between the 13th and 15th days of life) and its long duration in 2 out of 3 cases, the absence of infectious symptoms and the efficacy of erythromycin treatment were characteristic features. The diagnosis was confirmed by positive (greater than 1/32th) serological tests in both infants and parents. Chlamydia trachomatis lung infection should be suspected in infants presenting, during the first weeks of life, with cough and dyspnoea unaccompanied by fever, radiological evidence of interstitial pneumonia, blood eosinophilia and raised immunoglobulin levels. The disease results from intranatal contamination and might represent, in France as in the U.S.A., an important percentage of respiratory infections occurring during the early months of life.
- Published
- 1980
89. [Ocular prognosis in congenital toxoplasmosis: the role of treatment. Preliminary communication].
- Author
-
Couvreur J, Desmonts G, and Aron-Rosa D
- Subjects
- Humans, Prognosis, Prospective Studies, Toxoplasmosis, Congenital drug therapy, Chorioretinitis etiology, Toxoplasmosis, Congenital complications
- Published
- 1984
90. [Current aspects of the diagnosis and treatment of purulent pleurisy in children].
- Author
-
Baculard A, Tournier G, Grimfeld A, Couvreur J, and Gerbeaux J
- Subjects
- Acute Disease, Adolescent, Age Factors, Anti-Bacterial Agents therapeutic use, Anti-Inflammatory Agents therapeutic use, Child, Child, Preschool, Combined Modality Therapy, Cough etiology, Drainage, Drug Monitoring, Dyspnea etiology, Empyema, Pleural epidemiology, Empyema, Pleural etiology, Female, Fever etiology, Follow-Up Studies, Hemoptysis etiology, Humans, Incidence, Infant, Male, Microbial Sensitivity Tests, Respiratory Therapy, Time Factors, Treatment Outcome, Empyema, Pleural diagnosis, Empyema, Pleural therapy
- Published
- 1976
91. [An historical case of Marfan's syndrome].
- Author
-
Couvreur J
- Subjects
- Eye Manifestations, Famous Persons, History, 19th Century, Humans, Male, Marfan Syndrome genetics, Pedigree, United States, Marfan Syndrome diagnosis
- Published
- 1974
92. [Congenital toxoplasmosis: contribution of transfontanelle echotomography and computed tomography].
- Author
-
Neuenschwander S, Cordier MD, and Couvreur J
- Subjects
- Brain diagnostic imaging, Child, Preschool, Humans, Infant, Infant, Newborn, Toxoplasmosis, Congenital diagnostic imaging, Brain abnormalities, Tomography, X-Ray Computed, Toxoplasmosis, Congenital diagnosis, Ultrasonography methods
- Published
- 1984
93. [Legionella pneumophila pneumopathy in a 4 1/2-month-old infant].
- Author
-
Couvreur J, Khiati M, Petiot A, Dournon E, Voges A, Huault G, and Tournier G
- Subjects
- Female, Humans, Infant, Intensive Care Units, Legionnaires' Disease immunology, Legionnaires' Disease diagnosis
- Abstract
A 4 1/2 month-old infant presented with severe alveolo-interstitial pneumonitis needing intubation and mechanical ventilation. Legionella pneumophila infection was established by a significant increase in antibody titers. The clinical picture was consistent with that of legionnaires' disease. No immune defect could be proven.
- Published
- 1983
94. [Neonatal primary hyperparathyroidism in both dizygotic twins. Value of emergency parathyroidectomy].
- Author
-
Just J, Schmitt AM, Tournier G, Gruner M, Costil J, and Couvreur J
- Subjects
- Calcium blood, Female, Humans, Hyperparathyroidism blood, Hyperparathyroidism surgery, Infant, Newborn, Parathyroid Hormone blood, Twins, Dizygotic, Diseases in Twins, Hyperparathyroidism genetics, Parathyroid Glands surgery
- Published
- 1986
95. [Increased local production of specific G immunoglobulins in the cerebrospinal fluid in congenital toxoplasmosis].
- Author
-
Couvreur J, Desmonts G, Tournier G, and Collin F
- Subjects
- Adolescent, Adult, Antibody Specificity, Aqueous Humor immunology, Child, Child, Preschool, Female, Humans, Immunoglobulin G analysis, Infant, Infant, Newborn, Male, Toxoplasmosis, Congenital blood, Toxoplasmosis, Congenital cerebrospinal fluid, Immunoglobulin G cerebrospinal fluid, Toxoplasmosis, Congenital immunology
- Published
- 1984
96. [Pulmonary function testing in eight children after operation for left congenital diaphragmatic hernia (author's transl)].
- Author
-
Khouri-Dagher L, Gaultier C, Gruner M, Boule M, Couvreur J, Grimfeld A, and Girard F
- Subjects
- Child, Child, Preschool, Electromyography, Female, Hernias, Diaphragmatic, Congenital, Humans, Infant, Infant, Newborn, Lung abnormalities, Male, Postoperative Period, Respiratory Function Tests, Hernia, Diaphragmatic surgery, Lung physiopathology
- Published
- 1981
97. [Parasitic pathology of the fetus].
- Author
-
Couvreur J and Desmonts G
- Subjects
- Female, Humans, Infant, Newborn, Leishmaniasis, Visceral congenital, Malaria congenital, Pregnancy, Trypanosomiasis congenital, Protozoan Infections congenital, Toxoplasmosis, Congenital
- Published
- 1977
98. [Results of lung biopsy in interstitial pneumopathies in children. A report on 100 cases (author's transl)].
- Author
-
Boccon-Gibod L and Couvreur J
- Subjects
- Adolescent, Biopsy, Needle, Child, Child, Preschool, Hemosiderosis pathology, Humans, Infant, Lung Diseases pathology, Niemann-Pick Diseases pathology, Pneumonia pathology, Pulmonary Fibrosis etiology, Lung pathology, Pulmonary Fibrosis pathology
- Abstract
Needle biopsy was performed in 100 children with diffuse interstitial pneumopathy. Severe histological lesions were noted in the biopsy sections in 4 out 5 cases. Those most frequently observed (57 cases) were non-specific lesions of diffuse interstitial pneumopathy (DIP) or idiopathic fibrosis, the course of which was followed, in some cases, by repeating the biopsy. Specific lesions, especially idiopathic pulmonary hemosiderosis (8 cases), were noted in 22 children, either associated with interstitial fibrosis or apparently better tolerated. The other 16 cases included the lipoidoses (Niemann-Pick, histiocytosis X), alveolar microlithiasis, and some specific inflammatory diseases (tuberculosis, syphilis) or those related to inhalation of a foreign body.
- Published
- 1979
99. [Natural history of congenital toxoplasmosis].
- Author
-
Desmonts G and Couvreur J
- Subjects
- Female, Fetal Diseases immunology, Humans, Immunity, Maternally-Acquired, Infant, Newborn, Pregnancy, Pregnancy Complications, Infectious immunology, Toxoplasmosis, Congenital immunology, Fetal Diseases transmission, Pregnancy Complications, Infectious transmission, Toxoplasmosis, Congenital transmission
- Published
- 1984
100. [Human toxoplasmosis].
- Author
-
Desmonts G and Couvreur J
- Subjects
- Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious therapy, Toxoplasmosis, Congenital diagnosis, Toxoplasmosis diagnosis, Toxoplasmosis therapy
- Published
- 1977
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.